BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 25640522)

  • 1. Pediatric ovarian neoplastic tumors: incidence, age at presentation, tumor markers and outcome.
    Taskinen S; Fagerholm R; Lohi J; Taskinen M
    Acta Obstet Gynecol Scand; 2015 Apr; 94(4):425-9. PubMed ID: 25640522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovarian masses in children and adolescents - an analysis of 521 clinical cases.
    Zhang M; Jiang W; Li G; Xu C
    J Pediatr Adolesc Gynecol; 2014 Jun; 27(3):e73-7. PubMed ID: 24157281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian germ cell tumours: a 17-year study in a single unit.
    Panteli C; Curry J; Kiely E; Pierro A; de Coppi P; Anderson J; Sebire N; Drake D
    Eur J Pediatr Surg; 2009 Apr; 19(2):96-100. PubMed ID: 19360543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant ovarian germ cell tumors: clinico-pathological presentation and survival outcomes.
    Tangjitgamol S; Hanprasertpong J; Manusirivithaya S; Wootipoom V; Thavaramara T; Buhachat R
    Acta Obstet Gynecol Scand; 2010; 89(2):182-9. PubMed ID: 19961281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selecting treatment method for ovarian masses in children - 24 years of experience.
    Łuczak J; Bagłaj M
    J Ovarian Res; 2017 Sep; 10(1):59. PubMed ID: 28893324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue AP-2gamma and Oct-3/4, and serum CA 125 as diagnostic and prognostic markers of malignant ovarian germ cell tumors.
    Salonen J; Leminen A; Stenman UH; Butzow R; Heikinheimo M; Heikinheimo O
    Tumour Biol; 2008; 29(1):50-6. PubMed ID: 18497549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor markers in mature cystic teratomas of the ovary.
    Ustunyurt E; Gungor T; Iskender C; Ustunyurt BO; Bilge U; Mollamahmutoglu L
    Arch Gynecol Obstet; 2009 Feb; 279(2):145-7. PubMed ID: 18506458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum CA 125, carcinoembryonic antigen, and CA 19-9 as tumor markers in borderline ovarian tumors.
    Engelen MJ; de Bruijn HW; Hollema H; ten Hoor KA; Willemse PH; Aalders JG; van der Zee AG
    Gynecol Oncol; 2000 Jul; 78(1):16-20. PubMed ID: 10873403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of serum levels of tumor markers with tissue expression of gene products in ovarian carcinoma.
    Sorak M; Arsenijević S; Lukić G; Arsenijević N; Ristić P; Pavlović S; Popović S; Baskić D
    J BUON; 2007; 12(1):99-104. PubMed ID: 17436409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can we preoperatively risk stratify ovarian masses for malignancy?
    Oltmann SC; Garcia N; Barber R; Huang R; Hicks B; Fischer A
    J Pediatr Surg; 2010 Jan; 45(1):130-4. PubMed ID: 20105592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgery for ovarian masses in infants, children, and adolescents: 102 consecutive patients treated in a 15-year period.
    Cass DL; Hawkins E; Brandt ML; Chintagumpala M; Bloss RS; Milewicz AL; Minifee PK; Wesson DE; Nuchtern JG
    J Pediatr Surg; 2001 May; 36(5):693-9. PubMed ID: 11329568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovarian malignant mixed germ cell tumor with clear cell carcinoma in a postmenopausal woman.
    Yu XJ; Zhang L; Liu ZP; Shi YQ; Liu YX
    Int J Clin Exp Pathol; 2014; 7(12):8996-9001. PubMed ID: 25674278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian germ cell tumors in children. Management, survival and ovarian prognosis. A report of 75 cases.
    Vaysse C; Delsol M; Carfagna L; Bouali O; Combelles S; Lemasson F; Le Mandat A; Castex MP; Pasquet M; Moscovici J; Guitard J; Pienkowski C; Rubie H; Galinier P; Vaysse P
    J Pediatr Surg; 2010 Jul; 45(7):1484-90. PubMed ID: 20638529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transumbilical 1-port laparoscopic resection of benign ovarian tumor.
    Lee SY; Lee HM; Kao CY; Chuang JH
    J Pediatr Surg; 2012 Jul; 47(7):1340-4. PubMed ID: 22813793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
    Ulbright TM
    Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-operative differentiation of pediatric ovarian tumors: morphological scoring system and tumor markers.
    Stankovic ZB; Djukic MK; Savic D; Lukac BJ; Djuricic S; Sedlecki K; Zdravkovic D
    J Pediatr Endocrinol Metab; 2006 Oct; 19(10):1231-8. PubMed ID: 17172084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management and outcomes of ovarian masses in children and adolescents.
    Islam S; Yamout SZ; Gosche JR
    Am Surg; 2008 Nov; 74(11):1062-5. PubMed ID: 19062661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ovarian growing teratoma syndrome clinical study of 22 cases].
    Cheng NH; Huang HF; Lian LJ; Wu Y
    Zhonghua Fu Chan Ke Za Zhi; 2009 Jun; 44(6):426-30. PubMed ID: 19953942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor markers CA 125 and CA 19-9 in cord blood and during infancy: developmental changes and use in pediatric germ cell tumors.
    Lahdenne P; Pitkänen S; Rajantie J; Kuusela P; Siimes MA; Lanning M; Heikinheimo M
    Pediatr Res; 1995 Nov; 38(5):797-801. PubMed ID: 8552451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant ovarian germ cell tumors: identification of novel prognostic markers and long-term outcome after multimodality treatment.
    Murugaesu N; Schmid P; Dancey G; Agarwal R; Holden L; McNeish I; Savage PM; Newlands ES; Rustin GJ; Seckl MJ
    J Clin Oncol; 2006 Oct; 24(30):4862-6. PubMed ID: 17050871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.